![]() |
|
|


*
Department of Biochemistry, School of Medicine and the
Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111-1837
2To whom correspondence should be addressed at Silico Insights, Incorporated, 400 W. Cummings Park, Suite 6475, Woburn, MA 01801. E-mail: pankaj{at}silicoinsights.com.
Both estrogen-receptor (ER) positive MCF-7 and
ER-negative Hs578T and MDA-MB-231 human breast cancer cells were
treated with carotenoids (ß-carotene, canthaxanthin and lycopene) and
retinoids (all-trans-, 9-cis- and
13-cis-retinoic acid and
all-trans-retinol). Among carotenoids, ß-carotene
significantly reduced the growth of MCF-7 and Hs578T cells, and
lycopene inhibited the growth of MCF-7 and MDA-MB-231 cells.
Canthaxanthin did not affect the proliferation of any of the three cell
lines. All-trans- and 9-cis-retinoic acid
significantly reduced the growth of both MCF-7 and Hs578T cells,
whereas 13-cis-retinoic acid and
all-trans-retinol had a significant effect only on MCF-7
cells. MCF-7 and Hs578T cells treated with
all-trans-retinoic acid (all-t-RA) were
further studied for the mechanism behind growth inhibition. Retinoic
acid receptors
and
(RAR
,
) in MCF-7 cells and RAR
, ß
and
in Hs578T cells were not induced by all-t-RA
treatment at either the protein or mRNA level. Hs578T cells treated
with all-t-RA had significantly more cells in the G0/G1
stage of the cell cycle, but the same was not observed for MCF-7 cells.
All-t-RA induced a dose-dependent cell death in
MCF-7 cells, which may be a necrotic phenomenon. These results
demonstrate that ER status is an important, although not essential
factor for breast cancer cell response to carotenoid and retinoid
treatments, and the mode of action of all-t-RA in MCF-7
and Hs578T cells is not through the induction of RAR. Other mechanistic
pathways that are either followed by or concomitant with growth
inhibition are possible.
KEY WORDS: ß-carotene retinoic acid breast cancer cells cell cycle retinoic acid receptors
This article has been cited by other articles:
![]() |
H. D. Sesso, J. E. Buring, S. M. Zhang, E. P. Norkus, and J. M. Gaziano Dietary and Plasma Lycopene and the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1074 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ben-Dor, M. Steiner, L. Gheber, M. Danilenko, N. Dubi, K. Linnewiel, A. Zick, Y. Sharoni, and J. Levy Carotenoids activate the antioxidant response element transcription system Mol. Cancer Ther., January 1, 2005; 4(1): 177 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Chew and J. S. Park Carotenoid Action on the Immune Response J. Nutr., January 1, 2004; 134(1): 257S - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Sabichi, M. R. Modiano, J. J. Lee, Y.-M. Peng, M.-J. Xu, H. Villar, W. S. Dalton, and S. M. Lippman Breast Tissue Accumulation of Retinamides in a Randomized Short-term Study of Fenretinide Clin. Cancer Res., July 1, 2003; 9(7): 2400 - 2405. [Abstract] [Full Text] [PDF] |
||||